Rethinking Preeclampsia: How Placental Growth Factor Is Transforming Diagnosis and Management.

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Reproductive Health

Background:

• Preeclampsia is a major cause of maternal and fetal mortality worldwide.
• Current understanding of preeclampsia necessitates advancements in its prediction, diagnosis, and management.
• The condition affects pregnant individuals, their babies, and families, underscoring its significant impact.

Purpose of the Study:

• To review the role of placental growth factor (PlGF) in clinical practice.
• To explore how PlGF can enhance the prediction and diagnosis of preeclampsia.
• To discuss the potential of PlGF in managing preeclampsia and its complications.

Main Methods:

• Literature review focusing on placental growth factor (PlGF) and preeclampsia.
• Synthesis of current evidence on PlGF's utility in clinical settings.
• Presentation of findings at the Cannell Lecture, Society of Obstetricians & Gynaecologists of Canada.

Main Results:

• Placental growth factor (PlGF) shows promise in improving preeclampsia prediction.
• PlGF can aid in the timely diagnosis of preeclampsia.
• Utilizing PlGF can lead to better management strategies for preeclampsia and its sequelae.

Conclusions:

• Placental growth factor (PlGF) is a valuable biomarker for preeclampsia.
• Integrating PlGF into clinical workflows can improve patient outcomes.
• Further research and clinical adoption of PlGF are recommended for managing preeclampsia.